Both in Pharmaceuticals

BioAge Labs vs Turn Therapeutics

Over the past year BIOA returned −20.3% and TTRX returned +126.6%; their daily moves had a correlation of 0.04.

BIOA −20.3% TTRX +126.6%Growth of $1, one year, split-adjusted
MetricBIOATTRX
Price$5.95$9.80
Market cap$273.1M$297.6M
Today−0.17%+3.05%
1 month−5.4%−15.8%
6 months−67.8%+158.2%
Year to date−55.0%+148.7%
1 year−19.8%+121.7%
Revenue growth (YoY)+1.6%—
Gross margin100.0%—
Net margin−1064.7%—
P/E (TTM)——
Price / sales26.4×—
Net cash$318.7M$4.2M
Dividend yield——
Volatility (60d)66.2%89.4%
Short % of float12.0%3.0%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

BIOA vs TTRX: BioAge Labs vs Turn Therapeutics Stock Comparison | Gainbot